The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

Allies in Hope, formerly AIDS Foundation Houston, hosted the 36th Annual Walk to End HIV at Sam Houston Park in downtown ...

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

Without urgent intervention, Kenya risks a surge in new HIV infections, which currently stand at 16,752 annually, NSDCC said.